FDA sets advisory meeting date for Brainstorm’s ALS cell therapy

FDA sets advisory meeting date for Brainstorm’s ALS cell therapy

Submitted by admin on June 6, 2023 - 4:11pm
Source: 
BioPharma Dive
News Tags: 
BrainStorm Cell Therapeutics
FDA
NurOwn
cell therapy
ALS
Headline: 
FDA sets advisory meeting date for Brainstorm’s ALS cell therapy
snippet: 

The biotech will get another chance to make a case for its drug NurOwn during a Sept. 27 meeting of cell, tissue and gene therapy experts.

Do Not Allow Advertisers to Use My Personal information